ACADIA Pharmaceuticals Inc.
ACAD
$25.33
$0.803.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 626.84% | 13,484.97% | 469.50% | 186.36% | 127.58% |
| Total Depreciation and Amortization | 19.29% | 24.89% | 186.08% | 179.43% | 259.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -261.05% | -256.28% | -263.47% | 35.88% | 18.96% |
| Change in Net Operating Assets | 333.30% | 82.81% | -77.09% | -246.66% | -179.34% |
| Cash from Operations | 133.35% | 133.80% | 844.31% | 319.07% | 334.68% |
| Capital Expenditure | -1,540.00% | -946.00% | -946.00% | -40.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -650.58% | -64.20% | -650.83% | -1,144.34% | -794.35% |
| Cash from Investing | -250.03% | 19.48% | -195.44% | -1,148.40% | -795.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -12.12% | -69.08% | -72.76% | -51.62% | 157.69% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.12% | -69.08% | -72.76% | -51.62% | 157.69% |
| Foreign Exchange rate Adjustments | -937.50% | -845.45% | -422.22% | -228.57% | -300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.99% | 118.52% | 81.45% | 205.84% | 326.26% |